Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model
Open accessPublished version of a preprint
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
Severe cases of SARS-CoV-2 infection are characterized by hypercoagulopathies and systemic endotheliitis of the lung microvasculature. The dynamics of vascular damage, and whether it is a direct consequence of endothelial infection or an indirect consequence of an immune cell-mediated cytokine storm remain unknown. Using a vascularized lung-on-chip model, we find that infection of alveolar epithelial cells leads to limited apical release of virions, consistent with reports of monoculture infection. However, viral RNA and proteins are rapidly detected in underlying endothelial cells, which are themselves refractory to apical infection in monocultures. Although endothelial infection is unproductive, it leads to the formation of cell clusters with low CD31 expression, a progressive loss of barrier integrity and a pro-coagulatory microenvironment. Viral RNA persists in individual cells generating an inflammatory response, which is transient in epithelial cells but persistent in endothelial cells and typified by IL-6 secretion even in the absence of immune cells. Inhibition of IL-6 signalling with tocilizumab reduces but does not prevent loss of barrier integrity. SARS-CoV-2-mediated endothelial cell damage thus occurs independently of cytokine storm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · cited 1×
“On the other hand, infection resulted in increased expression of the TMPRSS2 protease (Hoffmann et al, 2020) required to cleave the spike protein for viral entry at 1 dpi in both cell types relative to uninfected controls (Fig 1F and I), with variable expression levels across chips.”
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613 · cited 2×
“Autopsy reports show numerous microvascular thrombi in the lungs of deceased patients together with evidence of the intracellular presence of the virus in vascular cells (Ackermann et al, 2020; Carsana et al, 2020).”
IL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046 · cited 10×
“No IL-6 was detected in the vascular effluent from uninfected controls.”
InfluentialReconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 1×
“The epithelial face was incubated with epithelial base medium with 1 µ M dexamethasone (Sigma-Aldrich) without FBS supplementation to promote tight junction formation and surfactant expression as reported in previous lung-on-chip studies(Huh et al, 2010; Hassell et al, 2017).”
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222 · cited 5×
“Similarly, most infections of alveolar epithelial cells are usually performed at high MOI (Blanco-Melo et al, 2020).”
InfluentialBhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305 · cited 1×
“Organ-on-chip technologies recreate key aspects of human physiology in a bottom-up and modular manner (Bhatia & Ingber, 2014).”
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984 · cited 1×
“We observed that low levels of intracellular viral RNA generate an NF-KB-mediated pro-inflammatory response, with suppression of antiviral interferon responses, consistent with reports of the effect of a number of viral proteins (Hadjadj et al, 2020; Thoms et al, 2020).”
The Architecture of SARS-CoV-2 Transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., & Chang, H. (2020) · Cell · doi:10.1016/j.cell.2020.04.011 · Cited by 2,123 · cited 1×
“…in replication kinetics can also be appreciated from the fact that whereas the N gene is most abundant during productive infection in Vero E6 cells (Kim et al, 2020), The detection of SARS-CoV-2 genomes in the endothelial layer within 1 dpi suggests rapid dissemination through basolateral transfer…”
Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122 · cited 4×
“Notably, NRP1 is likely to be located along the basal surface of the endothelial cells as an integrin-binding protein (Valdembri et al, 2009), and SARS-CoV-2 has been shown to infect vascularized organoids, albeit at high MOI (Monteil et al, 2020).”
InfluentialNeuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity
Cantuti-Castelvetri, L., Ojha, R., Pedro, L. D., Djannatian, M., Franz, J., Kuivanen, S., van der Meer, F., Kallio, K., Kaya, T., Anastasina, M., et al. (2020) · Science · doi:10.1126/science.abd2985 · Cited by 1,925 · cited 1×
“Neuropilin-1 (NRP1), an integrin-binding protein (Valdembri et al, 2009), has recently been reported to be an alternative receptor for SARS-CoV-2 entry (Cantuti-Castelvetri et al, 2020; Daly et al, 2020) that is highly expressed in pulmonary microvascular cells.”
Cited by
The cGAS–STING pathway drives type I IFN immunopathology in COVID-19
Domizio, J. D., Gulen, M. F., Saidoune, F., Thacker, V. V., Yatim, A., Sharma, K., Nass, T., Guenova, E., Schaller, M., Conrad, C., et al. (2022) · Nature · doi:10.1038/s41586-022-04421-w · Cited by 538
Self-citationImmunomodulation by endothelial cells — partnering up with the immune system?
Amersfoort, J., Eelen, G., & Carmeliet, P. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00694-4 · Cited by 525
Human disease models in drug development
Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331
Mucosal immune responses to infection and vaccination in the respiratory tract
Mettelman, R. C., Allen, E. K., & Thomas, P. G. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.013 · Cited by 271
“…infection of ECs by SARS-CoV-2; however, interaction with the virus lead to EC clustering, reduced CD31 expression, loss of barrier integrity, and production of pro-coagulation factors (Thacker et al., 2021), signs of severe disease that may be enhanced in aged individuals (Angelidis et al., 2019).”
Organ-on-a-chip meets artificial intelligence in drug evaluation
Deng, S., Li, C., Cao, J., Cui, Z., Du, J., Fu, Z., Yang, H., & Chen, P. (2023) · Theranostics · doi:10.7150/thno.87266 · Cited by 260
“matory response and loss of barrier integrity, the latter can be alleviated by tocilizumab treatment [255].”
BackgroundMethod
Metadata
- Authors
- Thacker, V. V., Sharma, K., Dhar, N., Mancini, G.-F., Sordet-Dessimoz, J., & McKinney, J. D.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- Corresponding author
- Thacker, Vivek V
- Sharma, Kunal
- Dhar, Neeraj
- Venue
- The EMBO Reports
- Published
- 2021-05-27
- Volume
- 22
- Issue
- 6
- Pages
- e52744-e52744
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC8183417
- OpenAlex
- W3159931117
- Cited by
- 142
- References
- 81
- Citations by year
- 2026: 17 · 2025: 25 · 2024: 17 · 2023: 30 · 2022: 36 · 2021: 16
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- Novartis Foundation for Medical-Biological Research ((#20C240))
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030B_176397)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Keywords
- SARS-CoV-2, endothelial inflammation, vascular injury, lung-on-a-chip, endothelial cell infection, alveolar epithelial cells, hypercoagulability, interleukin-6, tocilizumab, endothelial barrier integrity, viral RNA persistence, cytokine storm, COVID-19 pandemic
- MeSH terms
- Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Humans, Lung, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model. https://app.cochat.ai/papers/10.15252/embr.202152744
- The paper
- Thacker, V. V., Sharma, K., Dhar, N., Mancini, G.-F., Sordet-Dessimoz, J., & McKinney, J. D. (2021). Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model. The EMBO Reports. https://doi.org/10.15252/embr.202152744
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.